<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Q218 Total Joints Market Recap: Potential Market Softening

Posted by Lisa Mahan on 9/25/18 11:14 AM

Foreign currency exchange rates boosted reported WW market growth, while the US market failed to rebound as expected

In Q218, positive foreign currency exchange rates boosted reported growth again in the WW Total Joints Market, while the US market grew sequentially but with a less-than-expected rebound following challenges in Q118...

Among the many topics covered in detail in the Q218 Total Joints Market Recap are:

Read More

Topics: Orthopedics-Total Joints

SmartTRAK Publication Alert: Q118  Total Joints Market Recap

Posted by Lisa Mahan on 6/1/18 12:05 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Total Joints Market Recap.

Read More

Topics: Orthopedics-Total Joints

SmartTRAK's 2017 Total Joints Market Recap Financial Results

Posted by Lisa Mahan on 3/15/18 6:50 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care  companies, has published its 2017 Total Joints Market Recap and Financial Dashboard.

The Total Joints Market finished off a challenging year with accelerated growth in Q417, despite increasing pricing pressure. Hurricanes in Q3 and increased seasonality due to higher insurance deductibles pushed procedures into Q4 driving stronger sequential growth. Increasing penetration of robotics resulted in uptake of new products, including Stryker’s MAKO robotic TKA application for Triathlon knees.

Read More

Topics: Orthopedics-Total Joints

Q317 Total Joints Market: More than the Usual Seasonality

Posted by Lisa Mahan on 3/1/18 10:00 AM

Hurricanes Harvey and Irma disrupted procedures in the US during Q3, slowing growth beyond the typical seasonality. In the US, Q317 Total Joints Market growth was virtually flat YoY compared to 1.6% growth in Q316. However, stronger performances OUS, despite the India price cuts, helped offset the US decline resulting in WW Market reported growth of ... Download Article

Read More

Topics: Orthopedics-Total Joints

Catalyst OrthoScience Rethinks Total Shoulder Arthroplasty

Posted by Kristina Meyer on 12/21/17 5:48 PM

Catalyst OrthoScience speaks with SmartTRAK at the Orthopedic Summit Meeting (OSET) 2017 regarding the Company’s next generation total shoulder solution and its strategy for competing with the big players in this space

The Catalyst CSR Total Shoulder System is the result of the visionary insight of Steven Goldberg, MD, a fellowship-trained orthopedic surgeon and shoulder specialist, who devised the next generation, higher precision, less-invasive total shoulder solution with a greatly simplified method of implant placement. In 2011, Dr. Goldberg began development of the revolutionary implant with the new shape and created prototypes using a 3D printing service. Armed with two U.S. provisional patents and positive feedback from several prominent shoulder specialists, the Catalyst CSR Total Shoulder System was born.

Click on the video below to view SmartTRAK’s interview with Dr. Steven Goldberg, Founder & CMO, of Catalyst OrthoScience recorded live at the OSET meeting 2017.  (04:02 minutes)

 

Read More

Topics: Orthopedics-Total Joints

SmartTRAK Publication Alert: Q317 Total Joints Quarterly Market Recap

Posted by Lisa Mahan on 12/18/17 2:31 PM

Q317 Total Joints Market: More than the Usual SeasonalityMajor hurricanes in the US lead to softness in the quarter  

By Lisa Mahan, VP, Content Development, Ortho

The Imperfect Storms

Hurricanes Harvey and Irma disrupted procedures in the US during Q3 slowing growth beyond the typical seasonality. In the US, Q317 Total Joints Market growth was virtually flat YoY.

Read More

Topics: Orthopedics-Total Joints

Top 5 Trends in Joint Replacement

Posted by Lisa Mahan on 10/4/17 9:00 AM

Push Pull Trends in Joint Replacement Market Keep Growth Steady

Over the next twelve months, BioMedGPS projects the US Joint Replacement Market will grow in the low single digits at approximately 3%. This slow but steady growth is consistent with past years as the push pull of market trends keeps it in check. Gaining share in this era will require companies to navigate the changing political and economic landscape and to deliver solutions beyond launching the latest widget...

Read More

Topics: Orthopedics-Total Joints

Q217 Total Joints Market: Differing Approaches to Cost Containment

Posted by Lisa Mahan on 9/18/17 3:07 PM

India spoke loud and clear with extreme pricing caps on total knee replacements, while CMS sends mixed messages on controlling costs in the US

Outside the US the Total Joints Market softened during Q217, offsetting stable to strengthening results in US Knees and Hips, with the WW Market (as reported) growing +0.7%. Countries such as India are working to reduce the cost burden of joint replacement surgery, while in the US, the Centers for Medicaid & Medicare Services (CMS) is sending mixed messages keeping reimbursement rates relatively flat while proposing reductions to its Comprehensive Care for Joint Replacement bundled payments initiative...

Read More

Topics: Orthopedics-Total Joints

India's Cap on Knee implant Pricing May Slow Revenue Growth

Posted by Lisa Mahan on 9/5/17 11:41 AM

Max Retail Pricing for Knees in India Dropping up to 78%

The Indian Government enacted price controls for knee implants capping the price significantly below current market rates. According to a report in  IndiaToday , the move is the latest step in the government’s move to bring down the cost of medical devices and pharmaceuticals. The price controls for knee replacement implants caps the price of CoCr knees at ~$852 (54,720 rupees). Ananth Kumar, Minister of Chemicals and Fertilisers, stated current implants are priced at up to ~$3,895 (250K rupees) at Indian hospitals...

Read More

Topics: Orthopedics-Total Joints

Another Showdown in the Hyaluronic Acid Market?

Posted by Sharon O'Reilly on 4/25/17 5:00 PM

AAOS Shifts Focus From Efficacy to Cost

The American Association of Orthopedic Surgeons (AAOS) has shifted their focus from efficacy to costs in their offensive against intra-articular hyaluronic acid therapy

Read More

Topics: Orthopedics-Total Joints, Orthopedics-OrthoBio

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts